e8vk
 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

___________________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):     May 22, 2002

United Therapeutics Corporation


(Exact Name of Registrant as Specified in Charter)
         
Delaware   0-26301   52-1984749

 
 
(State or Other   (Commission   (I.R.S. Employer
Jurisdiction of   File Number)   Identification Number)
Incorporation)        
     
1110 Spring Street    
Silver Spring, MD   20910

 
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code:

(301) 608-9292


 


 

Item 5. Other Events.

     On May 22, 2002, the Registrant issued a press release attached hereto as Exhibit 99 and incorporated herein.

Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.

     
Exhibit No.   Description of Exhibit
 
99                   Press release of May 22, 2002

 


 

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
        United Therapeutics Corporation
(Registrant)
 
Date: May 29, 2002   By:   /s/ Fred T. Hadeed

Name: Fred T. Hadeed
Title: Chief Financial Officer

226502

 


 

Exhibit Index

     
Exhibit No.   Description of Exhibit
 
99                   Press release of May 22, 2002